• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

起源细胞将组织学类型谱与由突变型Kras和Lkb1缺失驱动的非小细胞肺癌中的免疫微环境多样性联系起来。

Cell of Origin Links Histotype Spectrum to Immune Microenvironment Diversity in Non-small-Cell Lung Cancer Driven by Mutant Kras and Loss of Lkb1.

作者信息

Nagaraj Ashwini S, Lahtela Jenni, Hemmes Annabrita, Pellinen Teijo, Blom Sami, Devlin Jennifer R, Salmenkivi Kaisa, Kallioniemi Olli, Mäyränpää Mikko I, Närhi Katja, Verschuren Emmy W

机构信息

Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki 00014, Finland.

HUSLAB, Division of Pathology, Helsinki University Hospital and University of Helsinki, Helsinki 00029, Finland.

出版信息

Cell Rep. 2017 Jan 17;18(3):673-684. doi: 10.1016/j.celrep.2016.12.059.

DOI:10.1016/j.celrep.2016.12.059
PMID:28099846
Abstract

Lung cancers exhibit pronounced functional heterogeneity, confounding precision medicine. We studied how the cell of origin contributes to phenotypic heterogeneity following conditional expression of Kras and loss of Lkb1 (Kras;Lkb1). Using progenitor cell-type-restricted adenoviral Cre to target cells expressing surfactant protein C (SPC) or club cell antigen 10 (CC10), we show that Ad5-CC10-Cre-infected mice exhibit a shorter latency compared with Ad5-SPC-Cre cohorts. We further demonstrate that CC10 cells are the predominant progenitors of adenosquamous carcinoma (ASC) tumors and give rise to a wider spectrum of histotypes that includes mucinous and acinar adenocarcinomas. Transcriptome analysis shows ASC histotype-specific upregulation of pro-inflammatory and immunomodulatory genes. This is accompanied by an ASC-specific immunosuppressive environment, consisting of downregulated MHC genes, recruitment of CD11b Gr-1 tumor-associated neutrophils (TANs), and decreased T cell numbers. We conclude that progenitor cell-specific etiology influences the Kras;Lkb1-driven tumor histopathology spectrum and histotype-specific immune microenvironment.

摘要

肺癌表现出明显的功能异质性,这给精准医学带来了困扰。我们研究了细胞起源如何在Kras条件性表达和Lkb1缺失(Kras;Lkb1)后导致表型异质性。使用祖细胞类型受限的腺病毒Cre靶向表达表面活性蛋白C(SPC)或支气管肺泡灌洗细胞抗原10(CC10)的细胞,我们发现与Ad5-SPC-Cre组相比,Ad5-CC10-Cre感染的小鼠潜伏期更短。我们进一步证明,CC10细胞是腺鳞癌(ASC)肿瘤的主要祖细胞,并产生更广泛的组织学类型,包括黏液性和腺泡性腺癌。转录组分析显示ASC组织学类型特异性的促炎和免疫调节基因上调。这伴随着ASC特异性的免疫抑制环境,包括MHC基因下调、CD11b Gr-1肿瘤相关中性粒细胞(TANs)募集以及T细胞数量减少。我们得出结论,祖细胞特异性病因会影响Kras;Lkb1驱动的肿瘤组织病理学谱和组织学类型特异性免疫微环境。

相似文献

1
Cell of Origin Links Histotype Spectrum to Immune Microenvironment Diversity in Non-small-Cell Lung Cancer Driven by Mutant Kras and Loss of Lkb1.起源细胞将组织学类型谱与由突变型Kras和Lkb1缺失驱动的非小细胞肺癌中的免疫微环境多样性联系起来。
Cell Rep. 2017 Jan 17;18(3):673-684. doi: 10.1016/j.celrep.2016.12.059.
2
Immunohistochemical Loss of LKB1 Is a Biomarker for More Aggressive Biology in KRAS-Mutant Lung Adenocarcinoma.免疫组织化学检测 LKB1 缺失是 KRAS 突变型肺腺癌中更具侵袭性生物学行为的生物标志物。
Clin Cancer Res. 2015 Jun 15;21(12):2851-60. doi: 10.1158/1078-0432.CCR-14-3112. Epub 2015 Mar 3.
3
Multiple cells-of-origin of mutant K-Ras-induced mouse lung adenocarcinoma.多种突变型 K-Ras 诱导的小鼠肺腺癌起源细胞。
Proc Natl Acad Sci U S A. 2014 Apr 1;111(13):4952-7. doi: 10.1073/pnas.1319963111. Epub 2014 Feb 28.
4
ETS1 regulates Twist1 transcription in a Kras/Lkb1 metastatic lung tumor model of non-small cell lung cancer.ETS1 在非小细胞肺癌的 Kras/Lkb1 转移性肺肿瘤模型中调节 Twist1 的转录。
Clin Exp Metastasis. 2018 Mar;35(3):149-165. doi: 10.1007/s10585-018-9912-z. Epub 2018 Jun 16.
5
Inhibition of autophagy and MEK promotes ferroptosis in Lkb1-deficient Kras-driven lung tumors.抑制自噬和 MEK 促进 Lkb1 缺失的 Kras 驱动的肺肿瘤中的铁死亡。
Cell Death Dis. 2023 Jan 26;14(1):61. doi: 10.1038/s41419-023-05592-8.
6
Co-occurring KRAS mutation/LKB1 loss in non-small cell lung cancer cells results in enhanced metabolic activity susceptible to caloric restriction: an in vitro integrated multilevel approach.非小细胞肺癌细胞中 KRAS 突变/LKB1 缺失的共存导致对热量限制敏感的增强代谢活性:一种体外综合多层次方法。
J Exp Clin Cancer Res. 2018 Dec 4;37(1):302. doi: 10.1186/s13046-018-0954-5.
7
Type I interferon signaling pathway enhances immune-checkpoint inhibition in KRAS mutant lung tumors.I 型干扰素信号通路增强 KRAS 突变肺肿瘤的免疫检查点抑制。
Proc Natl Acad Sci U S A. 2024 Sep 3;121(36):e2402913121. doi: 10.1073/pnas.2402913121. Epub 2024 Aug 26.
8
WEE1 Kinase Inhibitor AZD1775 Has Preclinical Efficacy in LKB1-Deficient Non-Small Cell Lung Cancer.WEE1 激酶抑制剂 AZD1775 在 LKB1 缺陷型非小细胞肺癌中有临床前疗效。
Cancer Res. 2017 Sep 1;77(17):4663-4672. doi: 10.1158/0008-5472.CAN-16-3565. Epub 2017 Jun 26.
9
PARP Inhibition Induces Synthetic Lethality and Adaptive Immunity in LKB1-Mutant Lung Cancer.PARP 抑制剂诱导 LKB1 突变型肺癌的合成致死和适应性免疫。
Cancer Res. 2023 Feb 15;83(4):568-581. doi: 10.1158/0008-5472.CAN-22-1740.
10
YAP promotes malignant progression of Lkb1-deficient lung adenocarcinoma through downstream regulation of survivin.YAP 通过下游调节存活素促进 Lkb1 缺陷型肺腺癌的恶性进展。
Cancer Res. 2015 Nov 1;75(21):4450-7. doi: 10.1158/0008-5472.CAN-14-3396. Epub 2015 Sep 11.

引用本文的文献

1
Plant polysaccharides influence tumor development based on epigenetics: a review.基于表观遗传学的植物多糖对肿瘤发展的影响:综述
Front Pharmacol. 2025 May 6;16:1588857. doi: 10.3389/fphar.2025.1588857. eCollection 2025.
2
The molecular features of lung cancer stem cells in dedifferentiation process-driven epigenetic alterations.去分化过程驱动的表观遗传改变中肺癌干细胞的分子特征。
J Biol Chem. 2024 Dec;300(12):107994. doi: 10.1016/j.jbc.2024.107994. Epub 2024 Nov 14.
3
Histological transformation in lung adenocarcinoma: Insights of mechanisms and therapeutic windows.
肺腺癌中的组织学转化:机制与治疗时机的见解
J Transl Int Med. 2024 Nov 6;12(5):452-465. doi: 10.1515/jtim-2024-0019. eCollection 2024 Nov.
4
Type I interferon signaling pathway enhances immune-checkpoint inhibition in KRAS mutant lung tumors.I 型干扰素信号通路增强 KRAS 突变肺肿瘤的免疫检查点抑制。
Proc Natl Acad Sci U S A. 2024 Sep 3;121(36):e2402913121. doi: 10.1073/pnas.2402913121. Epub 2024 Aug 26.
5
Distinctive field effects of smoking and lung cancer case-control status on bronchial basal cell growth and signaling.吸烟和肺癌病例对照状态对支气管基底细胞生长和信号的独特影响。
Respir Res. 2024 Aug 19;25(1):317. doi: 10.1186/s12931-024-02924-w.
6
Methionine Restriction Reduces Lung Cancer Progression and Increases Chemotherapy Response.蛋氨酸限制可降低肺癌进展并增强化疗反应。
bioRxiv. 2024 Jul 23:2024.06.25.599795. doi: 10.1101/2024.06.25.599795.
7
EML4-ALK fusions drive lung adeno-to-squamous transition through JAK-STAT activation.EML4-ALK 融合通过 JAK-STAT 激活驱动肺腺鳞转化。
J Exp Med. 2024 Mar 4;221(3). doi: 10.1084/jem.20232028. Epub 2024 Jan 29.
8
USP13 drives lung squamous cell carcinoma by switching lung club cell lineage plasticity.USP13 通过切换肺 club 细胞谱系可塑性驱动肺鳞状细胞癌。
Mol Cancer. 2023 Dec 13;22(1):204. doi: 10.1186/s12943-023-01892-x.
9
Using Artificial Intelligence to Identify Tumor Microenvironment Heterogeneity in Non-Small Cell Lung Cancers.利用人工智能识别非小细胞肺癌肿瘤微环境异质性。
Lab Invest. 2023 Aug;103(8):100176. doi: 10.1016/j.labinv.2023.100176. Epub 2023 May 12.
10
Targeted therapy for rare lung cancers: Status, challenges, and prospects.罕见肺癌的靶向治疗:现状、挑战与展望。
Mol Ther. 2023 Jul 5;31(7):1960-1978. doi: 10.1016/j.ymthe.2023.05.007. Epub 2023 May 13.